Author | Ghielmini, Michele | dc.contributor.author |
Author | Vitolo, Umberto | dc.contributor.author |
Author | Kimby, Eva K. | dc.contributor.author |
Author | Montoto, Silvia | dc.contributor.author |
Author | Walewski, Jan | dc.contributor.author |
Author | Pfreundschuh, Michael | dc.contributor.author |
Author | Federico, Mario | dc.contributor.author |
Author | Hoskin, Peter J. | dc.contributor.author |
Author | McNamara, Christopher | dc.contributor.author |
Author | Caligaris-Cappio, Federico | dc.contributor.author |
Author | Stilgenbauer, Stephan | dc.contributor.author |
Author | Marcus, R. | dc.contributor.author |
Author | Trneny, M. | dc.contributor.author |
Author | Dreger, P. | dc.contributor.author |
Author | Montserrat, E. | dc.contributor.author |
Author | Dreyling, M. | dc.contributor.author |
Author | 1st ESMO Consensus Conference | dc.contributor.author |
Date of accession | 2020-10-16T10:12:44Z | dc.date.accessioned |
Available in OPARU since | 2020-10-16T10:12:44Z | dc.date.available |
Date of first publication | 2013 | dc.date.issued |
Language | en | dc.language.iso |
Publisher | Universität Ulm | dc.publisher |
Keyword | chronic lymphocytic | dc.subject |
Keyword | consensus conference | dc.subject |
Keyword | diffuse large B-cell lymphoma | dc.subject |
Keyword | follicular lymphoma | dc.subject |
Keyword | leukemia | dc.subject |
Keyword | treatment | dc.subject |
Keyword | TERM-FOLLOW-UP | dc.subject |
Keyword | POSITRON-EMISSION-TOMOGRAPHY | dc.subject |
Keyword | NON-HODGKINS-LYMPHOMA | dc.subject |
Keyword | HIGH-DOSE THERAPY | dc.subject |
Keyword | FLUDARABINE PLUS CYCLOPHOSPHAMIDE | dc.subject |
Keyword | PREVIOUSLY UNTREATED PATIENTS | dc.subject |
Keyword | RANDOMIZED CONTROLLED-TRIAL | dc.subject |
Keyword | PROGRESSION-FREE SURVIVAL | dc.subject |
Keyword | DETUDE DES LYMPHOMES | dc.subject |
Keyword | ELDERLY-PATIENTS | dc.subject |
Dewey Decimal Group | DDC 610 / Medicine & health | dc.subject.ddc |
Title | ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL) | dc.title |
Resource type | Wissenschaftlicher Artikel | dc.type |
Institution | UKU. Klinik für Innere Medizin III | uulm.affiliationSpecific |
DCMI Type | Text | uulm.typeDCMI |
Category | Publikationsnachweise | uulm.category |
DOI (external) | 10.1093/annonc/mds517 | dc.identifier.doiExternal |
Source - Title of source | Annals of Oncology | source.title |
Source - Place of publication | Oxford University Press | source.publisher |
Source - Volume | 24 | source.volume |
Source - Issue | 3 | source.issue |
Source - Year | 2013 | source.year |
Source - From page | 561 | source.fromPage |
Source - To page | 576 | source.toPage |
Source - ISSN | 0923-7534 | source.identifier.issn |
Source - eISSN | 1569-8041 | source.identifier.eissn |
Open Access | Bronze, Green Published | uulm.OA |
Community | Universitätsklinikum Ulm | uulm.community |
WoS | 000316504900001 | uulm.identifier.wos |
Bibliography | uulm | uulm.bibliographie |